Instagram Story Save

How might sequencing by expansion (SBX) technology advance critical care in the future? Get the insights - link in bio.

(The SBX technology is in development and not commercially available. The content of this material reflects current study results and/or design goals.)

#Genomics #HumanGenetics #RocheSBX #Innovation #NGS

Hypertension doesn’t shout, it whispers — often for years — before it causes harm.

On #WorldHypertensionDay, we’re raising awareness of why early detection, consistent monitoring and shared responsibility are critical to protecting long‑term heart health.

Because continuous control of blood pressure isn’t achieved alone. We do it together.

Hypertension doesn’t shout, it whispers — often for years — before it causes harm.

On #WorldHypertensionDay, we’re raising awareness of why early detection, consistent monitoring and shared responsibility are critical to protecting long‑term heart health.

Because continuous control of blood pressure isn’t achieved alone. We do it together.

Hypertension doesn’t shout, it whispers — often for years — before it causes harm.

On #WorldHypertensionDay, we’re raising awareness of why early detection, consistent monitoring and shared responsibility are critical to protecting long‑term heart health.

Because continuous control of blood pressure isn’t achieved alone. We do it together.

Hypertension doesn’t shout, it whispers — often for years — before it causes harm.

On #WorldHypertensionDay, we’re raising awareness of why early detection, consistent monitoring and shared responsibility are critical to protecting long‑term heart health.

Because continuous control of blood pressure isn’t achieved alone. We do it together.

Hypertension doesn’t shout, it whispers — often for years — before it causes harm.

On #WorldHypertensionDay, we’re raising awareness of why early detection, consistent monitoring and shared responsibility are critical to protecting long‑term heart health.

Because continuous control of blood pressure isn’t achieved alone. We do it together.

Hypertension doesn’t shout, it whispers — often for years — before it causes harm.

On #WorldHypertensionDay, we’re raising awareness of why early detection, consistent monitoring and shared responsibility are critical to protecting long‑term heart health.

Because continuous control of blood pressure isn’t achieved alone. We do it together.

Hypertension doesn’t shout, it whispers — often for years — before it causes harm.

On #WorldHypertensionDay, we’re raising awareness of why early detection, consistent monitoring and shared responsibility are critical to protecting long‑term heart health.

Because continuous control of blood pressure isn’t achieved alone. We do it together.

A new era in Alzheimer's diagnostics is here!

We're moving past procedures perceived to be invasive to simple, accurate blood technology, with the pTau217 protein showing excellent accuracy to support timely diagnosis.

Link in bio!

#Innovation #Healthcare #Technology #Alzheimers #Neuroscience

A new era in Alzheimer's diagnostics is here!

We're moving past procedures perceived to be invasive to simple, accurate blood technology, with the pTau217 protein showing excellent accuracy to support timely diagnosis.

Link in bio!

#Innovation #Healthcare #Technology #Alzheimers #Neuroscience

A new era in Alzheimer's diagnostics is here!

We're moving past procedures perceived to be invasive to simple, accurate blood technology, with the pTau217 protein showing excellent accuracy to support timely diagnosis.

Link in bio!

#Innovation #Healthcare #Technology #Alzheimers #Neuroscience

A new era in Alzheimer's diagnostics is here!

We're moving past procedures perceived to be invasive to simple, accurate blood technology, with the pTau217 protein showing excellent accuracy to support timely diagnosis.

Link in bio!

#Innovation #Healthcare #Technology #Alzheimers #Neuroscience

A new era in Alzheimer's diagnostics is here!

We're moving past procedures perceived to be invasive to simple, accurate blood technology, with the pTau217 protein showing excellent accuracy to support timely diagnosis.

Link in bio!

#Innovation #Healthcare #Technology #Alzheimers #Neuroscience

Science is at its best when it creates new possibilities.

At Roche, we have spent two decades mapping the intricate pathways of the immune system. Today, we are applying that knowledge to target the roots of complex diseases like COPD, IBD, and Lupus.
We are not just looking at how to treat conditions—we are looking at how to re-program the biology behind them. Because every breakthrough expands the horizon of what is possible, giving more people the chance to live on their own terms.

Link in Bio: Explore the Science

This #WorldLupusDay, we’re raising awareness of the real-world impact of lupus and the realities facing millions of people around the world every day. 💜

Lupus is a complex, systemic condition where the immune system attacks healthy tissue. It is often invisible, with symptoms that mimic other conditions—leading to a long, challenging road to diagnosis.
In this video, Jeanette, who lives with #SystemicLupusErythematosus (SLE), shares what real progress in care would look like and her hope for the future.

Let’s help make lupus visible.

#WorldLupusDay2026 #LupusAwareness #SLE

This #LupusAwarenessMonth, we’re listening to patient voices to help build greater understanding of the real-world impact of lupus and what matters most to people living with the condition.

We’re sharing the stories of Jeanette and Amy, who are living with #SystemicLupusErythematosus and #LupusNephritis, respectively, as they reflect on how lupus can affect day-to-day life – from daily treatment routines to long-term aspirations.

#LivingWithLupus #SLE #Lupus

Could sequencing by expansion (SBX) technology unlock new possibilities in cancer research? Click the link in our bio to find out more.

(The SBX technology is in development and not commercially available. The content of this material reflects current study results and/or design goals.)

#Genomics #HumanGenetics #RocheSBX #Innovation #NGS

Parkinson’s changed Scott’s rhythm - but it didn’t stop him. 🥁

Scott’s story is a reminder of why progress matters; because people living with Parkinson’s deserve better answers and a future beyond symptoms.

👉 Read more about Scott’s story by clicking on the link in our bio.

Parkinson’s changed Scott’s rhythm - but it didn’t stop him. 🥁

Scott’s story is a reminder of why progress matters; because people living with Parkinson’s deserve better answers and a future beyond symptoms.

👉 Read more about Scott’s story by clicking on the link in our bio.

Parkinson’s changed Scott’s rhythm - but it didn’t stop him. 🥁

Scott’s story is a reminder of why progress matters; because people living with Parkinson’s deserve better answers and a future beyond symptoms.

👉 Read more about Scott’s story by clicking on the link in our bio.

Parkinson’s changed Scott’s rhythm - but it didn’t stop him. 🥁

Scott’s story is a reminder of why progress matters; because people living with Parkinson’s deserve better answers and a future beyond symptoms.

👉 Read more about Scott’s story by clicking on the link in our bio.

Some diseases challenge not only patients, but also the boundaries of scientific understanding.

Myelin oligodendrocyte glycoprotein antibody-associated disease (#MOGAD) is one of them — a rare and complex condition of the central nervous system that continues to push the need for deeper research and clearer differentiation.

When conditions present with overlapping characteristics, advancing knowledge becomes essential. Because behind every accurate diagnosis is the possibility of more appropriate care, better decisions, and improved patient outcomes.

This is where long-term commitment to research makes a difference.
Through continuous investment in science, collaboration with the medical community, and a focus on innovation, Roche is working to better understand diseases like MOGAD — helping to bring clarity where uncertainty still exists.

Progress in rare diseases requires persistence. And the belief that every unanswered question is an opportunity to go further.

Some diseases challenge not only patients, but also the boundaries of scientific understanding.

Myelin oligodendrocyte glycoprotein antibody-associated disease (#MOGAD) is one of them — a rare and complex condition of the central nervous system that continues to push the need for deeper research and clearer differentiation.

When conditions present with overlapping characteristics, advancing knowledge becomes essential. Because behind every accurate diagnosis is the possibility of more appropriate care, better decisions, and improved patient outcomes.

This is where long-term commitment to research makes a difference.
Through continuous investment in science, collaboration with the medical community, and a focus on innovation, Roche is working to better understand diseases like MOGAD — helping to bring clarity where uncertainty still exists.

Progress in rare diseases requires persistence. And the belief that every unanswered question is an opportunity to go further.

Some diseases challenge not only patients, but also the boundaries of scientific understanding.

Myelin oligodendrocyte glycoprotein antibody-associated disease (#MOGAD) is one of them — a rare and complex condition of the central nervous system that continues to push the need for deeper research and clearer differentiation.

When conditions present with overlapping characteristics, advancing knowledge becomes essential. Because behind every accurate diagnosis is the possibility of more appropriate care, better decisions, and improved patient outcomes.

This is where long-term commitment to research makes a difference.
Through continuous investment in science, collaboration with the medical community, and a focus on innovation, Roche is working to better understand diseases like MOGAD — helping to bring clarity where uncertainty still exists.

Progress in rare diseases requires persistence. And the belief that every unanswered question is an opportunity to go further.

Some diseases challenge not only patients, but also the boundaries of scientific understanding.

Myelin oligodendrocyte glycoprotein antibody-associated disease (#MOGAD) is one of them — a rare and complex condition of the central nervous system that continues to push the need for deeper research and clearer differentiation.

When conditions present with overlapping characteristics, advancing knowledge becomes essential. Because behind every accurate diagnosis is the possibility of more appropriate care, better decisions, and improved patient outcomes.

This is where long-term commitment to research makes a difference.
Through continuous investment in science, collaboration with the medical community, and a focus on innovation, Roche is working to better understand diseases like MOGAD — helping to bring clarity where uncertainty still exists.

Progress in rare diseases requires persistence. And the belief that every unanswered question is an opportunity to go further.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

Healthcare saves lives. But it also leaves a footprint.

Climate change is already shaping people’s health — so how we innovate matters more than ever.

At Roche, sustainability means operating with a long-term mindset: ensuring more people can benefit from our innovation today without compromising the world they will live in tomorrow.

Because human health and planetary health are inextricably linked. 🌍

Here’s our approach to environmental sustainability.

🩸This #WorldHemophiliaDay, we honour the strength of everyone living with haemophilia A.

The condition impacts far more than health: planning, uncertainty and fear of bleeding can shape daily life. But advances in care mean children born today can start protection from day one, offering a brighter future.

Together with @wfhemophilia, we’re committed to better protection and better outcomes for all.Tap the link in our bio to learn more 🔗.

#WHD2026 #Hemophilia

When antibiotics stop working, every infection can become a fight for life. 🩺

Today, we share the story of Vanessa, who survived a devastating car crash — only to face a drug-resistant infection that no antibiotic seemed able to stop.

Despite repeated treatments, the bacteria had adapted. Living with AMR meant years of uncertainty, multiple surgeries, and constant fear. Vanessa eventually overcame the infection and now advocates for responsible antibiotic use and early diagnosis — helping others understand the real human impact of drug resistance.

Her experience shows why tackling antimicrobial resistance (AMR) is so critical. That’s why our scientists are committed to developing advanced diagnostics and entirely new classes of antibiotics, protecting patients today and for generations to come.

Click the link in bio to read the full story from our Annual Review! 👇